Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Heart Failure

  Free Subscription


5 Am Heart J
2 Am J Cardiol
2 Ann Thorac Surg
1 Basic Res Cardiol
1 Cardiovasc Res
3 Circ Heart Fail
2 Circulation
1 Coron Artery Dis
2 Eur Heart J
9 Eur J Heart Fail
3 Int J Cardiol
4 J Am Coll Cardiol
4 J Card Fail
2 J Cardiovasc Pharmacol
2 Lancet

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. KOSHY AN, Dinh DT, Fulcher J, Brennan AL, et al
    Long-Term Mortality in Asymptomatic Patients with Stable Ischemic Heart Disease undergoing Percutaneous Coronary Intervention.
    Am Heart J. 2021 Nov 12. pii: S0002-8703(21)00449.
    PubMed         Abstract available

  2. VON LEWINSKI D, Tripolt NJ, Sourij H, Pferschy PN, et al
    Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) - A phase III study.
    Am Heart J. 2022;246:152-160.
    PubMed         Abstract available

  3. HIGGINS AY, Annapureddy AR, Wang Y, Minges KE, et al
    Risk and Predictors of Mortality After Implantable Cardioverter-Defibrillator Implantation in Patients with Sarcoid Cardiomyopathy.
    Am Heart J. 2021 Dec 27. pii: S0002-8703(21)00491.
    PubMed         Abstract available

  4. CAVENDER MA, O'Donoghue M, Abbate A, Aylward P, et al
    Inhibition of p38 MAP Kinase in Patients with ST-Elevation Myocardial Infarction - Findings from the LATITUDE TIMI 60 Trial.
    Am Heart J. 2021 Sep 8. pii: S0002-8703(21)00229.
    PubMed         Abstract available

  5. RASMUSSEN PV, Blanche P, Dalgaard F, Gislason GH, et al
    Electrical cardioversion of atrial fibrillation and the risk of brady-arrhythmic events: Rasmussen et al: Electrical cardioversion and bradycardia.
    Am Heart J. 2021 Oct 16. pii: S0002-8703(21)00434.
    PubMed         Abstract available

    Am J Cardiol

  6. PERRY AS, Mudigonda P, Huang GS, Qureshi B, et al
    Long-Term Outcomes and Risk Stratification of Patients With Heart Failure With Recovered Ejection Fraction.
    Am J Cardiol. 2022 Apr 2. pii: S0002-9149(22)00245.
    PubMed         Abstract available

  7. PATOULIAS D, Doumas M, Kassimis G, Fragakis N, et al
    Meta-Analysis Evaluating the Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Acute or Recently Decompensated Heart Failure.
    Am J Cardiol. 2022 Apr 5. pii: S0002-9149(22)00260.

    Ann Thorac Surg

  8. NOVELLIS P, Monaco F, Landoni G, Rossetti F, et al
    Venoarterial Extracorporeal Membrane Oxygenator Support in Lung Cancer Resection.
    Ann Thorac Surg. 2021 Jun 7. pii: S0003-4975(21)00998.
    PubMed         Abstract available

  9. ALWAIR H, Whitehouse K, Slaughter MS, Trivedi JR, et al
    A Tale of Two Centrifugal Flow Ventricular Assist Devices as Bridge to Heart Transplant.
    Ann Thorac Surg. 2021 Apr 12. pii: S0003-4975(21)00674.
    PubMed         Abstract available

    Basic Res Cardiol

  10. WANG Z, Qiu Z, Hua S, Yang W, et al
    Nuclear Tkt promotes ischemic heart failure via the cleaved Parp1/Aif axis.
    Basic Res Cardiol. 2022;117:18.
    PubMed         Abstract available

    Cardiovasc Res

  11. Corrigendum to: Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF.
    Cardiovasc Res. 2022 Apr 9. pii: 6565889. doi: 10.1093.

    Circ Heart Fail

  12. DI LODOVICO E, Facondo P, Delbarba A, Pezzaioli LC, et al
    Testosterone, Hypogonadism, and Heart Failure.
    Circ Heart Fail. 2022 Apr 8:101161CIRCHEARTFAILURE121008755.
    PubMed         Abstract available

  13. HUGHES ZH, Ning H, Shah SJ, Yancy CW, et al
    Distribution of 10- and 30-Year Predicted Risks for Heart Failure in the US Population: National Health and Nutrition Examination Surveys 2015 to 2018.
    Circ Heart Fail. 2022 Apr 4:CIRCHEARTFAILURE121009351.

  14. VEST AR, Wong WW, Chery J, Coston A, et al
    Skeletal Muscle Mass Recovery Early After Left Ventricular Assist Device Implantation in Patients With Advanced Systolic Heart Failure.
    Circ Heart Fail. 2022 Apr 5:101161CIRCHEARTFAILURE121009012.
    PubMed         Abstract available


  15. CAO Y, Pan C, Wang YC, Zhou Z, et al
    Identification of DNA Damage Repair Enzyme Ascc2 as Causal for Heart Failure With Preserved Ejection Fraction.
    Circulation. 2022;145:1102-1104.

  16. KOSIBOROD MN, Angermann CE, Collins SP, Teerlink JR, et al
    Effects of Empagliflozin on Symptoms, Physical Limitations and Quality of Life in Patients Hospitalized for Acute Heart Failure - Results From the EMPULSE Trial.
    Circulation. 2022 Apr 4. doi: 10.1161/CIRCULATIONAHA.122.059725.
    PubMed         Abstract available

    Coron Artery Dis

  17. ABBADI AB, Lemesle G, Lamblin N, Bauters C, et al
    Very long-term outcomes of older adults with stable coronary artery disease (from the CORONOR study).
    Coron Artery Dis. 2022;33:169-175.
    PubMed         Abstract available

    Eur Heart J

  18. TROMP J, Ouwerkerk W, Teng TK, Cleland JGF, et al
    Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction.
    Eur Heart J. 2022 Apr 8. pii: 6564923. doi: 10.1093.
    PubMed         Abstract available

  19. KHAN MS, Bakris GL, Packer M, Shahid I, et al
    Kidney function assessment and endpoint ascertainment in clinical trials.
    Eur Heart J. 2022;43:1379-1400.
    PubMed         Abstract available

    Eur J Heart Fail

  20. TOMASONI D, Adamo M, Metra M
    March 2022 at a glance: focus on medical therapy, prevention and comorbidities.
    Eur J Heart Fail. 2022;24:403-405.

  21. DAUW J, Mullens W, Girerd N
    The fastest way to the heart is through the veins: towards a better understanding of congestion.
    Eur J Heart Fail. 2022;24:463-465.

  22. KOEHLER F, Schulz M
    The AMULET menage a trois: nurse, telemedicine support, and remote cardiologist.
    Eur J Heart Fail. 2022;24:578-580.

  23. DONAL E, Sade LE, Thomas L
    Left atrial function: the HbA1c for the cardiologist and even more.
    Eur J Heart Fail. 2022;24:494-496.

  24. CURTAIN JP, Jackson AM, Shen L, Jhund PS, et al
    Effect of sacubitril/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF.
    Eur J Heart Fail. 2022;24:551-561.
    PubMed         Abstract available

  25. RUSSO G, Taramasso M, Pedicino D, Gennari M, et al
    Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities?
    Eur J Heart Fail. 2022;24:442-454.
    PubMed         Abstract available

  26. IVEY-MIRANDA JB, Wetterling F, Gaul R, Sheridan S, et al
    Changes in inferior vena cava area represent a more sensitive metric than changes in filling pressures during experimental manipulation of intravascular volume and tone.
    Eur J Heart Fail. 2022;24:455-462.
    PubMed         Abstract available

  27. AMAT-SANTOS IJ, Sanchez-Luna JP, Abu-Assi E, Melendo-Viu M, et al
    Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.
    Eur J Heart Fail. 2022;24:581-588.
    PubMed         Abstract available

  28. DE SOUSA C, Pinto FJ
    Dapagliflozin post-transcatheter aortic valve implantation: the need for further evidence.
    Eur J Heart Fail. 2022;24:589-590.

    Int J Cardiol

  29. MAHABADI AA, Anapliotis V, Dykun I, Hendricks S, et al
    Epicardial fat and incident heart failure with preserved ejection fraction in patients with coronary artery disease.
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00489.
    PubMed         Abstract available

  30. SENGUPTA SP, Okwose NC, MacGowan GA, Jakovljevic DG, et al
    Peak atrio-ventricular mechanics predicts exercise tolerance in heart failure patients.
    Int J Cardiol. 2022 Mar 31. pii: S0167-5273(22)00442.
    PubMed         Abstract available

  31. STASSEN J, Khidir M, Galloo X, Hirasawa K, et al
    Prognostic implications of staging cardiac remodeling in patients undergoing cardiac resynchronization therapy.
    Int J Cardiol. 2022;355:65-71.
    PubMed         Abstract available

    J Am Coll Cardiol

  32. HEIDENREICH PA, Bozkurt B, Aguilar D, Allen LA, et al
    2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    J Am Coll Cardiol. 2022 Mar 24. pii: S0735-1097(21)08394.
    PubMed         Abstract available

  33. GHAZI L, Yamamoto Y, Riello RJ, Coronel-Moreno C, et al
    Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.
    J Am Coll Cardiol. 2022 Mar 19. pii: S0735-1097(22)04489.
    PubMed         Abstract available

  34. VAN SPALL HGC, Fonarow GC, Mamas MA
    Under-utilization of Guideline-Directed Medical Therapy in Heart Failure: Can Digital Health Technologies PROMPT Change?
    J Am Coll Cardiol. 2022 Mar 24. pii: S0735-1097(22)04564.

  35. HEIDENREICH PA, Bozkurt B, Aguilar D, Allen LA, et al
    2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    J Am Coll Cardiol. 2022 Mar 24. pii: S0735-1097(21)08395.
    PubMed         Abstract available

    J Card Fail

  36. HEIDENREICH PA, BozkurtChair B, Aguilar D, Allen LA, et al
    2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    J Card Fail. 2022 Mar 17. pii: S1071-9164(22)00075.
    PubMed         Abstract available

  37. JENTZER JC, Reddy YN, Rosenbaum AN, Dunlay SM, et al
    Outcomes and predictors of mortality among cardiac intensive care unit patients with heart failure.
    J Card Fail. 2022 Mar 22. pii: S1071-9164(22)00448.
    PubMed         Abstract available

  38. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.
    J Card Fail. 2022 Mar 14. pii: S1071-9164(22)00076.
    PubMed         Abstract available

    A Clinician's Guide to the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure.
    J Card Fail. 2022 Mar 22. pii: S1071-9164(22)00451.

    J Cardiovasc Pharmacol

  40. RUSSO V, Ammendola E, Gasperetti A, Bottino R, et al
    Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients.
    J Cardiovasc Pharmacol. 2022;79:472-478.
    PubMed         Abstract available

  41. POLLESELLO P, Kivikko M
    Renal impairment in patients with acute heart failure: Are inotropes safe?
    J Cardiovasc Pharmacol. 2022 Apr 1. pii: 00005344-990000000-00016.


  42. EZEKOWITZ JA, Colin-Ramirez E, Ross H, Escobedo J, et al
    Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial.
    Lancet. 2022;399:1391-1400.
    PubMed         Abstract available

  43. BECK-DA-SILVA L, Rohde LE
    Reduction of dietary sodium for heart failure: a step forward.
    Lancet. 2022;399:1361-1363.

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.